Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

PF Equity Holdings 2 B.V. — Allogene Therapeutics, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / PF Equity Holdings 2 B.V.

PF Equity Holdings 2 B.V.

10% owner at Allogene Therapeutics, Inc. · on record since Sep 20, 2021

Insider trading activity of PF Equity Holdings 2 B.V.

Transactions on record: 1; since Apr 4, 2022

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Apr 4, 2022

Figures computed from official regulatory filings — methodology.

Companies where PF Equity Holdings 2 B.V. has traded

Allogene Therapeutics, Inc.1 tx · Apr 4, 2022

Track record of PF Equity Holdings 2 B.V.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of PF Equity Holdings 2 B.V.

Co-insiders of PF Equity Holdings 2 B.V.

Amado RafaelAllogene Therapeutics, Inc.
Barrett Elizabeth A.Allogene Therapeutics, Inc.
Belldegrun ArieAllogene Therapeutics, Inc.
Beneski Benjamin MachinasAllogene Therapeutics, Inc.
Bhavnagri VeerAllogene Therapeutics, Inc.
BONDERMAN DAVIDAllogene Therapeutics, Inc.
Chang David DAllogene Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

CHEN YINLIN JACKAllogene Therapeutics, Inc.

COULTER JAMES GAllogene Therapeutics, Inc.

DEYOUNG JOHN A.Allogene Therapeutics, Inc.

Douglas Earl MartinAllogene Therapeutics, Inc.

Humer Franz BAllogene Therapeutics, Inc.

KAZAM JOSHOA AAllogene Therapeutics, Inc.

Mayo StephenAllogene Therapeutics, Inc.

MESSEMER DEBORAH M.Allogene Therapeutics, Inc.

MOORE ALISONAllogene Therapeutics, Inc.

MOORE TIMOTHY L.Allogene Therapeutics, Inc.

Parker Geoffrey M.Allogene Therapeutics, Inc.

PFIZER INCAllogene Therapeutics, Inc.

Roberts ZacharyAllogene Therapeutics, Inc.

SATO VICKI LAllogene Therapeutics, Inc.

SCHMIDT ERIC THOMASAllogene Therapeutics, Inc.

Sisitsky Todd BenjaminAllogene Therapeutics, Inc.

Smith LillianAllogene Therapeutics, Inc.

TPG GP A, LLCAllogene Therapeutics, Inc.

TPG Group Holdings (SBS) Advisors, Inc.Allogene Therapeutics, Inc.

WINKELRIED JONAllogene Therapeutics, Inc.

WITTE OWEN N.Allogene Therapeutics, Inc.

Yoshiyama AnnieAllogene Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Allogene Therapeutics, Inc.	Apr 4, 2022	Other	-22,032,040	0.00 USD	$0	SEC